PharmaFrontiers to Present at Marcus Evans Conference, "Facing Stem Cell Research Challenges"
News Jun 07, 2006
PharmaFrontiers Corp. has announced that David B. McWilliams, chief executive officer of PharmaFrontiers, will make a presentation entitled, "Embracing the Realities of Stem Cell Commercialization," at the upcoming Marcus Evans conference.
The presentation will be given on June 9, 2006 at the Hyatt Regency Hotel in San Francisco at 3:30 pm pacific time.
A copy of the presentation will be posted to the Company's Web site following Mr. McWilliams' talk.
In his presentation, Mr. McWilliams will discuss PharmaFrontiers' proprietary stem cell technology, which uses adult pluripotent stem cells derived from patients' own circulating blood.
In addition, he will discuss the key factors for success in the commercialization of stem cell therapies and the ways in which PharmaFrontiers is able to address the challenges facing the available technologies.
T Cells Attack and Kill Dopamine-Producing Cells in Parkinson's diseaseNews
Researchers in Germany discover a potential new target for treating Parkinson's diseaseREAD MORE
The “Traffic Cop” Protein Which Gives Progenitor Cells Permission to DifferentiateNews
Knowledge of this dictating protein may help find therapies for the injured brain and affect glial tumor cell researchREAD MORE
Regenerative Medicine Meets Clever Engineering to Accommodate Bone GraftsNews
Personalized bone grafts developed to repair bone defects from disease or injuryREAD MORE